e 4031 has been researched along with Acute Lymphoid Leukemia in 1 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pillozzi, S | 1 |
| Masselli, M | 1 |
| De Lorenzo, E | 1 |
| Accordi, B | 1 |
| Cilia, E | 1 |
| Crociani, O | 1 |
| Amedei, A | 1 |
| Veltroni, M | 1 |
| D'Amico, M | 1 |
| Basso, G | 1 |
| Becchetti, A | 1 |
| Campana, D | 1 |
| Arcangeli, A | 1 |
1 other study available for e 4031 and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Membrane; Cells, Cultured; Coculture Techniq | 2011 |